Search Results - "Ruggieri S"

New oral drugs for multiple sclerosis.

Authors: Gasperini, Claudio Ruggieri, S.

Source: Neurological Sciences. Oct2009 Supplement 1, Vol. 30, p179-183. 5p.

Subjects: Multiple sclerosis treatment, Drugs, Disease relapse, Fumarates, Neurology

DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy).

Authors: Fornai, F. Lenzi, P. G. Frenzilli et al.

Source: Psychopharmacology. 2004, Vol. 173 Issue 3/4, p353-363. 11p. 5 Graphs.

Subjects: Serotonin, Dopamine, Neurotoxicology, Ecstasy (Drug), Substantia nigra, Laboratory mice

This result is not displayed to guests.
Login for full access.

Nuclear valve stem packing improvements can reduce leakage.

Authors: Ruggieri, S. K.

Source: Power Engineering; September 1986, Vol. 90, p26-29, 4p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Glycosyl and polyalcoholic prodrugs of lonidamine

Authors: Giorgioni, G. Ruggieri, S. Di Stefano, A. et al.

Source: Bioorganic & Medicinal Chemistry Letters. Apr2008, Vol. 18 Issue 7, p2445-2450. 6p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Sleep disturbances in Parkinson's disease.

Authors: Stocchi, F. Brusa, L. Vacca, L. et al.

Source: European Journal of Neurology. Nov2000 Supplement 4, Vol. 7, p21-25. 5p. 2 Charts, 1 Graph.

Subjects: Sleep disorders, Neurological disorders, Parkinson's disease, Quality of life, Extrapyramidal disorders, Brain diseases

Optimizing levodopa pharmacokinetics in Parkinson's disease: the role of COMT inhibitor.

Authors: Stocchi, F. Vacca, L. Grassini, P. et al.

Source: Neurological Sciences. Oct2003, Vol. 24 Issue 3, p217-218. 2p.

Subjects: Parkinson's disease, Pharmacokinetics, Metabolism, Dopa

Amphetamines induce ubiquitin-positive inclusions within striatal cells.

Authors: Fornai, F. Lazzeri, G. Lenzi, P. et al.

Source: Neurological Sciences. Oct2003, Vol. 24 Issue 3, p182-183. 2p.

Subjects: Amphetamines, Ubiquitin, GABA, Cells, Nervous system, Dopamine, Neurons

Combination of two different dopamine agonists in the management of Parkinson's disease.

Authors: Stocchi, F. Berardelli, A. Vacca, L. et al.

Source: Neurological Sciences. Sep2002 Supplement 2, Vol. 23, pS115. 2p.

Subjects: Parkinson's disease, Dopamine agonists

Noradrenergic loss enhances MDMA toxicity and induces ubiquitin-positive striatal whorls.

Authors: Ferrucci, M. Gesi, M. Lenzi, P. et al.

Source: Neurological Sciences. Sep2002 Supplement 2, Vol. 23, pS75. 2p.

Subjects: Movement disorders, Neurodegeneration, Basal ganglia, Parkinson's disease, Ecstasy (Drug)

Presymptomatic tests in Huntington's disease and dominant ataxias.

Authors: Cannella, M. Simonelli, M. D'Alessio, C. et al.

Source: Neurological Sciences. Feb2001, Vol. 22 Issue 1, p55-56. 2p.

Subjects: Huntington disease, Ataxia

Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results.

Authors: Stocchi, F. Vacca, L. De Pandis, M. F. et al.

Source: Neurological Sciences. Feb2001, Vol. 22 Issue 1, p93-94. 2p. 2 Graphs.

Subjects: Parkinson's disease, Dopa, Dopamine agonists